
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ERT has announced a partnership with the neuroscience technology company, Cogstate, Ltd. The collaboration enables ERT to expand its electronic Clinical Outcome Assessment solution with digital cognitive endpoint measurement aiming to improve safety and efficacy assessment in clinical trials.
For more information, click






